ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 64

Rab4A Controls mTOR Pathway Activation, Pro-inflammatory Lineage Development, and Disease Pathogenesis in Lupus-prone Mice

Nick Huang1, Zhiwei Lai 2, Brandon Wyman 2, Thomas Winans 2, Manuel Duarte 2, Joshua Lewis 2, Mark Haas 3, Laurence Morel 4 and Andras Perl 5, 1Upstate Medical University, Syracuse, NY, 2Upstate Medical University, Syracuse, 3Cedars-Sinai Medical Center, Los Angeles, CA, 4University of Florida, Gainesville, FL, 5SUNY Upstate Medical University, Syracuse, NY

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Autoimmunity, metabolism and endosomal trafficking, mTor, SLE

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: SLE – Animal Models Poster

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Mouse models of SLE have been indispensable tools for studying disease pathogenesis; however, each model only recapitulates limited aspects of lupus. SLE1.2.3. (TC) mice are mice homozygous for three NZM2410-derive lupus susceptibility loci on the C57Bl/6J background. These mice develop systemic autoimmunity with fatal glomerulonephritis and die typically by 12 months of age. The polymorphic Rab4a locus has been associated with genetic susceptibility and protection from lung disease in SLE patients and has been found to be overexpressed in T cells of patients and mice with SLE. To determine the impact of this gene on disease development, the TC mice has been backcrossed with C57Bl/6 wild-type (WT) mice that carry floxed Rab4AQ72L (TC-FL) alleles or lack Rab4A in T cells (TC-KO).

Methods: Proteinuria was assessed by the Bradford assay. ANA production was measured by ELISA. Mice were sacrificed around 50 weeks of age for analysis via flow cytometry, Seahorse assay and mass spectrometry. Histological scoring for glomerulonephritis (GN) was done blindly by Dr. Mark Haas.

Results: TC mice had increased proteinuria (males 160%, p=0.035, females 230%, p=0.008) over matched controls. Deletion of Rab4A in T cells reduced proteinuria (-50%, p=0.015) in female TC-KO mice relative to TC-FL mice at 21 and 40 weeks of age (TC-FL: 0.85±0.2 mg/ml, n=22; TC-KO: 0.39±0.1 mg/ml; n=12; p=0.041). Similar trends were noted in male mice (TC-FL: 1.01±0.1 mg/ml, TC-KO: 0.79±0.1 mg/ml; p=0.048). ANA production was reduced in male (-70.3%, p=0.009) and female (-24%, p=0.003) TC-KO mice relative to TC mice at 23 weeks of age. GN scores were significantly elevated (425%, p=0.009) in female TC mice compared to WT control at 53 weeks of age. Importantly, TC-KO mice showed a reduction (-40%; p=0.0342) in GN severity over TC-FL mice.  

Immunophenotyping unveiled a 45% depletion of CD4+ T cells (p=0.003) and 50% expansion of CD8+ T cells (p=0.016) in TC-KO female mice relative to TC-FL controls. Interestingly, mTORC1 activity in CD4+ was elevated by 100% in TC and by 290% (p=3E-05) in TC-FL mice, an effect that is diminished in TC-KO mice by 47% compared to TL-FL mice (p=0.0395). The same effect was not observed in CD8+ T cells or B cells of TC-KO mice. Additionally, IFNy-producing CD4+ T cells were expanded by 370% in TC (p=0.042) and by 310% in TC-FL mice (p=0.025). These proinflammatory cells were depleted by 47% in the TC-KO mice relative to lupus-prone TC mice.  

Relative to WT controls, flow cytometry revealed elevated mitochondrial mass (+38%, p=0.0416) and that occurred with a reduction in mitochondrial potential in CD4+ T cells of TC mice (53%, p=0.009). Seahorse metabolic analysis unveiled increased mitochondrial basal respiration (+80%, p=0.024), maximal respiration (+48%, p=0.02), ATP production (+84%, p=0.023) and spare respiratory capacity (+174%, p< 0.001) in CD8+ T cells of TC-WT mice relative to WT controls.

Conclusion: These findings establish how Rab4A promotes mTOR pathway activation, pro-inflammatory T cell lineage development, and disease pathogenesis through its influence on mitochondrial metabolism in SLE. Therefore, inactivation of Rab4A may have therapeutic potential in SLE.


Disclosure: N. Huang, None; Z. Lai, None; B. Wyman, None; T. Winans, None; M. Duarte, None; J. Lewis, None; M. Haas, None; L. Morel, None; A. Perl, None.

To cite this abstract in AMA style:

Huang N, Lai Z, Wyman B, Winans T, Duarte M, Lewis J, Haas M, Morel L, Perl A. Rab4A Controls mTOR Pathway Activation, Pro-inflammatory Lineage Development, and Disease Pathogenesis in Lupus-prone Mice [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/rab4a-controls-mtor-pathway-activation-pro-inflammatory-lineage-development-and-disease-pathogenesis-in-lupus-prone-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rab4a-controls-mtor-pathway-activation-pro-inflammatory-lineage-development-and-disease-pathogenesis-in-lupus-prone-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology